The interactions between VCAM-1 present on BM MSCs and VLA-4 expressed on CLL cells mediate the retention of leukemic cells in the BM microenvironment, thus promoting drug resistance [55,58]. The gene discussed is VCAM1; the disease is B-cell chronic lymphocytic leukemia.